刘肖君,曾敏,符秀虹,何杨利,陈积雄. 血清miR-302b在老年急性心肌梗死中的表达及其临床意义[J]. 中国急救医学, 2019, 39(7): 678-681.
Liu Xiao-jun, Zeng Min, Fu Xiu-hong, He Yang-li, Chen Ji-xiong. Expression of serum miR-302b in elderly patients with acute myocardial infarction and its clinical significance. Chinese Journal of Critical Care Medicine, 2019, 39(7): 678-681.
[1]Deng D, Liu L, Xu G, et al. Epidemiology and Serum Metabolic Characteristics of Acute Myocardial Infarction Patients in Chest Pain Centers[J]. Iran J Public Health, 2018, 47(7): 1017-1029.
[2]Chen Z, Li C, Lin K, et al. MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers[J]. Anatol J Cardiol, 2018, 19(2): 140-147.
[3]Qu W, Shi S, Sun L, et al. Construction of a microRNA associated feed forward loop network that identifies regulators of cardiac hypertrophy and acute myocardial infarction[J]. Int J Mol Med, 2018, 42(4): 2062-2070.
[4]Li G, Song Y, Li YD, et al. Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure[J]. Biomark Med, 2018, 12(8): 871-880.
[5]Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision[J]. Int J Epidemiol, 2011, 40(1): 139-146.
[6]Mueller C, Auer J, Halvorsen S. Cardiac troponin elevations in acute non-coronary disease: Helpful or not[J]. Eur Heart J Acute Cardiovasc Care, 2015, 4(5): 429-430.
[7]Eggers KM, Lindahl B. Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome[J]. Clin Chem, 2017, 63(1): 223-235.
[8]Wu K, Zhao Q, Li Z, et al. Bioinformatic screening for key miRNAs and genes associated with myocardial infarction[J]. FEBS Open Bio, 2018, 8(6): 897-913.
[9]Sun T, Dong YH, Du W, et al. The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application[J]. Int J Mol Sci, 2017, 18(4): E745.
[10]Boeddinghaus J, Twerenbold R, Nestelberger T, et al. Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction[J]. Clin Chem, 2018, 64(9): 1347-1360.
[11]Fan J, Ma J, Xia N, et al. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction[J]. Clin Lab, 2017, 63(3): 427-433.
[12]陈劲松,刘访遥,刘运阳,等. miR-214在老年急性心肌梗死患者血清中的表达及其临床意义[J]. 中国急救医学, 2018, 38(4): 341-344.
[13]Guo ML, Guo LL, Weng YQ. Implication of peripheral blood miRNA-124 in predicting acute myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2017, 21(5): 1054-1059.
[14]Wang ZH, Sun XY, Li CL, et al. miRNA-21 Expression in the Serum of Elderly Patients with Acute Myocardial Infarction[J]. Med Sci Monit, 2017, 23(12): 5728-5734.
[15]Yang S, Fu C, Xu R, et al. Serum microRNA-302b: the novel biomarker for diagnosis of acute myocardial infarction[J]. Br J Biomed Sci, 2017, 74(4): 214-216.
[16]Wang C, Jing Q. Non-coding RNAs as biomarkers for acute myocardial infarction[J]. Acta Pharmacol Sin, 2018, 39(7): 1110-1119.